info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
United States Flag  US: +1-315-636-4233    United Kingdom Flag  UK: +44-162-237-0614    Indian Flag  IN: +91-826-083-6500
smrlogonew
  • Home
  • About
    • Why SMR
    • Research Methodology
    • Media Coverage
    • Join Our Team
  • Reports
    • Aerospace and Defense
    • Agriculture
    • Automotive
    • Chemicals and Materials
    • Consumer Goods
    • Energy and Power
    • Equipment and Machinery
    • Food and Beverages
    • Healthcare
    • Information and Communication Technology
    • Semiconductor and Electronics
    • Manufacturing and Construction
  • Our Practices
    • Syndicated Research
    • Consulting Services
    • Custom Research
    • Full-time Engagement Model
  • Insights
    • Press Release
    • Blog
  • Contact
Home » Press Releases » Digital Therapeutics Market will be worth USD 35.78 billion by 2030.

Digital Therapeutics Market will be worth USD 35.78 billion by 2030.


Published Date: Apr-2022 | Report Format:Electronic (PDF)

The report Digital Therapeutics Market by Sales Channel (B2b and B2C), Product Type (Software, Device), Application (Preventive Applications, Treatment/Care-related Applications), and Regions- Global Forecast to 2030.” The Global Digital Therapeutics Market share was USD 2.3 billion in 2020. It is predicted to reach USD 35.78 billion by 2030, representing a CAGR of 31.4 percent throughout the forecasted period”. 

 

To know more about the report, Click on the link :- https://www.strategicmarketresearch.com/market-report/digital-therapeutics-market

 

KEY FACTORS AUGMENTING THE MARKET GROWTH

Some of the most notable factors that are majorly driving the overall growth of the market worldwide are an increase in chronic diseases, majorly among the geriatric people, the adoption of mobile phones and tablets, the need to control the cost, and an increase in focus on preventive health care. 

 

By sales channel, the B2B held the highest market share in 2020 

Based on sales channels, the Digital Therapeutics industry worldwide has broadly classified into B2C (Patients and Caregivers) and B2B (Providers, Payers, Employers, and Pharmaceutical Companies). The B2B segment dominated the overall market with a steady digital therapeutic device market CAGR which is attributed to the increase in awareness among payers, providers, and employers about the benefits of digital therapeutics and wellness with the inclination of pharmaceutical companies to integrate digital therapeutics with drug products.

 

By Product Type, the software segment held the highest market share in 2020

Based on Product Type, the Digital Therapeutics industry worldwide has broadly classified into software and Devices. The software segment dominated the overall market during the 2020 market share due to the increase in the adoption of mobile phones and usage of the internet across developing nations. 

 

By Application, the Treatment/Care-related Applications held the largest market share in 2020

Based on Application, the Digital Therapeutics industry worldwide has broadly classified into Preventive Applications (Prediabetes, Obesity, Nutrition, Lifestyle Management) and Treatment/Care-related Applications (Diabetes, CNS Disorders (Mental Health Disorder) Chronic Respiratory Disorders, Musculoskeletal Disorders, Cardiovascular Diseases, Smoking Cessation, Medication Adherence, Gastrointestinal Disorders, Substance Use & Addiction Management, Rehabilitation & Patient Care). The Treatment/Care-related Applications dominated the overall market during the 2020 market share, with diabetes as a significant revenue generator in 2020 due to the increase in the chronic diseases such as obesity, increase in the economic burden of treatment, and cost and also investments in digital therapeutics market to make it cost-effective and scalable.

 

Based on Region, North America held the significant market share and is also expected to grow at the highest CAGR, with US digital therapeutics market as a major one, followed by Europe's digital therapeutics market, which is due to the factors such as the Increase in the new start-ups, government initiatives to support technological advancements, and increasing investments in digital therapeutics that drive market growth in this region.

 

Key Competitive Players 

Some of the crucial players in the Global Digital Therapeutics Market include 2MORROW, Inc., Akili Interactive Labs, Inc., Click Therapeutics, Inc., Fitbit, Inc. (Twine Health, Inc.), Happify, Inc., Kaia Health, Livongo Health, Inc., Medtronic Plc., Omada Health, Inc., Pear Therapeutics, Inc., Proteus Digital Health, Inc., Resmed, Inc. (Propeller Health), Voluntis, Inc., Welldoc, Inc., f-star therapeutics, omega therapeutics,g1 therapeutics, gsk digital therapeutics, q digital, viridian therapeutics

 

Recent Developments: -

  • In April 2021, Welldoc partnered with Dexcom, which helped provide BlueStar with a single platform for improved health for people suffering from Type II diabetes, which brought together the two most challenging and independent elements of diabetes management – glucose monitoring and the impact of lifestyle choices through a new app experience through which users will be able to manage multiple facets of their health while also improving data sharing with their care team. 
  • In March 2021, Tufts Health Plan and Spectrum Health Systems collaborated with Pear Therapeutics to test FDA with approved digital therapeutics to help people with substance use disorders and improve their recovery journeys by delivering solutions for improved treatment access and care innovation journeys.

Choose License Type



$0
$0
$0
Buy Now
"Click to avail the latest sample copy of the report"
Request Sample
"Probe before placing the order"
Pre-Order Enquiry
"Let's optimize your ROI by furnishing the best price"
Request Discount
"Want to curate the report according to your business needs:"
Ask for Customization

Trust Online

  • paypal.png
  • wiretransfers

Follow Us

  • facebook
  • twitter
  • instagram
  • linkedin

Contact Us

  • US: (+1) 315-636-4233
  • UK: (+44) 1622-370-614
  • IN: (+91) 826-083-6500
  • info@strategicmarketresearch.com
  • Strategic Market Research
    26, Broadway Suite 934, New York , 10004

Quick Link

  • Why SMR
  • Research Methodology
  • Media Coverage
  • Join Our Team
  • Press Release
  • Blog

Customer Support

  • FAQs
  • Contact
  • Terms of Use
  • Privacy Policy
  • Disclaimer Policy
  • Return Policy
Copyright © 2022 Strategic Market Research All rights reserved